Chilton Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.25K Buy
+53
New +$7.4K ﹤0.01% 521
2024
Q4
Sell
-143
Closed -$21.3K 658
2024
Q3
$21.3K Hold
143
﹤0.01% 425
2024
Q2
$18K Buy
+143
New +$22.4K ﹤0.01% 454

Other funds holding RGEN

Chilton Capital Management's RGEN Position: Q1 2026 in Review

Chilton Capital Management opened a new position in Repligen (RGEN) in Q1 2026: 53 shares worth $6.25K. The stake represents ﹤0.01% of the portfolio and ranks #521 among its holdings. This is a return to the name: Chilton Capital Management previously reported a position in RGEN as recently as Q3 2024.

Chilton Capital Management first reported a position in RGEN in Q2 2024 and has held it in 3 quarters since. The position peaked at $21.3K in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Chilton Capital Management held 53 shares of Repligen worth $6.25K as of Q1 2026.
  • Repligen was a new Chilton Capital Management position in Q1 2026.
  • Repligen made up ﹤0.01% of Chilton Capital Management's portfolio in Q1 2026, its #521 holding.
  • Chilton Capital Management first reported a position in Repligen in Q2 2024 and has held it in 3 quarters since.
  • Chilton Capital Management's Repligen position peaked at $21.3K in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Chilton Capital Management's 13F filing for Q1 2026, filed 11 May 2026.